Anmelden Kostenlos registrieren

Apellis Pharmaceuticals Inc Quick ratio

Was ist das Quick ratio von Apellis Pharmaceuticals Inc?

Quick ratio von Apellis Pharmaceuticals Inc ist 4.04

Was ist die Definition von Quick ratio?



Einzugsliquidität (Quick Ratio) ist die Liquiditätsquote, die die Fähigkeit eines Unternehmens misst, seine kurzfristigen Vermögenswerte zur sofortigen Erfüllung seiner kurzfristigen Verpflichtungen einzusetzen.

The quick ratio is the ratio between quick or liquid assets and current liabilities. Quick assets include those current assets that presumably can be quickly converted to cash at close to their book values. A normal liquid ratio is considered to be 1. A company with a quick ratio of less than 1 cannot at the time fully pay its current liabilities or short-term obligations. This ratio is considered to be a much reliable tool for assessment of liquidity position of companies.

Quick ratio von Unternehmen in Health Care Sektor auf NASDAQ im Vergleich zu Apellis Pharmaceuticals Inc

Was macht Apellis Pharmaceuticals Inc?

apellis pharmaceuticals is an early stage biotechnology company applying immunotherapy to auto-immune diseases, with an initial emphasis on diseases of the lungs such as asthma and chronic obstructive pulmonary disease (copd), diseases of the retina such as age-related macular degeneration (amd), and rare hematological diseases such as paroxysmal nocturnal hemoglobinuria (pnh). apellis believes that targeting a key element in the immune system called the complement system can have profound disease modifying benefits. we call this approach complement immunotherapy.

Unternehmen mit quick ratio ähnlich Apellis Pharmaceuticals Inc